Data from clinicaltrials.gov - Curated by EPG Health - Last updated 27 September 2019

The primary objective is to evaluate the benefit of acetylsalicylic acid and atorvastatin on overall survival (OS) (main endpoint) for patients with castrate-resistant prostate cancer starting first line treatment for CRPC.

purpose

This is a 2x2 factorial randomized, multicenter, international, open phase III trial.

The primary objective is to evaluate the benefit of acetylsalicylic acid and atorvastatin on overall survival (OS) (main endpoint) for patients with castrate-resistant prostate cancer starting first line treatment for CRPC.


Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 1210 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Intervention Model Description: This is a 2x2 factorial randomized, multicenter, international, open phase III trial
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase III Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Estimated Study Start Date: March 2019
Estimated Primary Completion Date: March 2034
Estimated Study Completion Date: March 2038

Arms:
- No Intervention:
Arm A
- Experimental: Arm B
- Experimental: Arm C
- Experimental: Arm D

Category Value
Date last updated at source 28-Jan-19
Study type(s) Interventional
Expected enrolment 1210
Study start date 01-Mar-19
Estimated primary completion date 01-Mar-34

View full details

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Load more

Related Content